Guidelines for Anticoagulation Therapy for Secondary Prevention After Deep Vein Thrombosis
Recurrence Rate
June 2011
When trying to ascertain how long to treat patients with idiopathic venous thrombotic events, the first thing I like to share with patients is the anticipated recurrence rate or natural history and what you can tell them what the ten year risk of recurrence will be. After an idiopathic thrombotic event, the 10-year risk of recurrence is about 30 percent as shown on this slide.
Recurrence Rate |
Jump to section:
- Introduction
- Independent Risk Factors for Venous Thromboembolism1
- Thrombophilia Testing
- ACCP Treatment Duration Guidelines2
- Aggressive Thrombophilia2
- Case
- Case
- Recurrence Rate
- ACCP Treatment Duration Guidelines3
- D-Dimer Levels and Risk of Recurrent Venous Thromboembolism4
- PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation5
- PROLONG: D-Dimer Testing to Determine Duration of Anticoagulation5
- Idiopathic VTE
- Residual Vein Thrombosis (RVT) to Assess Optimal Management of DVT: DACUS Study6
- Residual Vein Thrombosis (RVT) to Determine Duration of Anticoagulation6
- Recurrent VTE by RVT at 3 Months: DACUS Study6
- Non-compressed vs. Compressed
- Idiopathic DVT: Take Home Point
- Case (revisited)
- Case (revisited)
- Mortality Risk
- Cumulative Recurrence of DVT vs PE After Incident DVT
- Cumulative Recurrence of DVT vs PE After Incident PE
- Independent Predictors of Death within 7 Days of Venous Thromboembolism Recurrence
- Idiopathic PE – Take Home Points
- References
- Clinical and Laboratory Update in Thrombosis and Anticoagulation
- Questions?
External
link
PDF
document
Excel
document
Word
document